Skip to main content

Jones James's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Dec 23, 2022

Accession no.
0001209191-22-062654
Filed
Dec 23, 2022
Trade date
Dec 1-21, 2022
Filing delay
22 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 15 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.49K. It was filed 22 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones JamesCIK 0001490829Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 1, 2022Common StockPPurchaseAcquired+31$2.33+$72.2325,657Direct
Dec 2, 2022Common StockPPurchaseAcquired+31$2.31+$71.6125,688Direct
Dec 5, 2022Common StockPPurchaseAcquired+31$2.19+$67.8925,719Direct
Dec 6, 2022Common StockPPurchaseAcquired+31$2.19+$67.8925,750Direct
Dec 7, 2022Common StockPPurchaseAcquired+31$2.18+$67.5825,781Direct
Dec 8, 2022Common StockPPurchaseAcquired+31$2.19+$67.8925,812Direct
Dec 9, 2022Common StockPPurchaseAcquired+31$2.15+$66.6525,843Direct
Dec 12, 2022Common StockPPurchaseAcquired+31$2.14+$66.3425,874Direct
Dec 13, 2022Common StockPPurchaseAcquired+40$2.18+$87.225,914Direct
Dec 14, 2022Common StockPPurchaseAcquired+40$2.21+$88.425,954Direct
Dec 15, 2022Common StockPPurchaseAcquired+20$2.24+$44.825,974Direct
Dec 16, 2022Common StockPPurchaseAcquired+40$2.22+$88.826,014Direct
Dec 19, 2022Common StockPPurchaseAcquired+70$2.21+$154.726,084Direct
Dec 20, 2022Common StockPPurchaseAcquired+121$2.31+$279.5126,205Direct
Dec 21, 2022Common StockPPurchaseAcquired+88$2.22+$195.3626,293Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)